Related Experiment Video
Updated: Jul 20, 2026

Basic Research in Plasma Medicine - A Throughput Approach from Liquids to Cells
Published on: November 17, 2017
Measurement of plasma-derived substance P: biological, methodological, and statistical considerations
Donald E Campbell1, Nancy Raftery, Richard Tustin
1Division of Allergy and Immunology, Joseph Stokes Jr. Research Institute, The Children's Hospital of Philadelphia, 34th and Civic Center Blvd., Philadelphia, PA 19104, USA. campbelld@email.chop.edu
Abstract:
The undecapeptide substance P (SP) is a member of the tachykinin family of neurotransmitters, which has a pivotal role in the regulation of inflammatory and immune responses. One of the major barriers to the study of the in vivo role of SP in a number of immune disorders is the accurate measurement of SP in fluids. This is reflected in the variability of reported SP levels in serum and plasma of humans in both healthy and diseased states. This study was initiated in order to identify sources of variability by the comparative evaluation of the influences of sample preparation and analytical detection methods on the measurement of SP in plasma. The results indicate that sample preparation (peptide extraction versus no extraction) and the choice of analytical method for SP quantitation may yield significantly different values and may contribute to the variability in SP values reported in the literature. These results further emphasize the need for careful consideration in the selection of methods for SP quantitation, as well as caution in the interpretation and comparison of data reported in the literature.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Drug Concentrations: Measurements
Plasma —...
Measurement of Bioavailability: Pharmacokinetic Methods
Bioequivalence Data: Statistical Interpretation
